ISPD Produces CDP-ribitol Used by FKTN and FKRP to Transfer Ribitol Phosphate Onto α-dystroglycan
Overview
Authors
Affiliations
Mutations in genes required for the glycosylation of α-dystroglycan lead to muscle and brain diseases known as dystroglycanopathies. However, the precise structure and biogenesis of the assembled glycan are not completely understood. Here we report that three enzymes mutated in dystroglycanopathies can collaborate to attach ribitol phosphate onto α-dystroglycan. Specifically, we demonstrate that isoprenoid synthase domain-containing protein (ISPD) synthesizes CDP-ribitol, present in muscle, and that both recombinant fukutin (FKTN) and fukutin-related protein (FKRP) can transfer a ribitol phosphate group from CDP-ribitol to α-dystroglycan. We also show that ISPD and FKTN are essential for the incorporation of ribitol into α-dystroglycan in HEK293 cells. Glycosylation of α-dystroglycan in fibroblasts from patients with hypomorphic ISPD mutations is reduced. We observe that in some cases glycosylation can be partially restored by addition of ribitol to the culture medium, suggesting that dietary supplementation with ribitol should be evaluated as a therapy for patients with ISPD mutations.
Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice.
Cataldi M, Lu Q Sci Rep. 2025; 15(1):1329.
PMID: 39779805 PMC: 11711661. DOI: 10.1038/s41598-024-83661-4.
Qualtieri A, De Benedittis S, Cerantonio A, Citrigno L, Di Palma G, Gallo O Int J Mol Sci. 2024; 25(19).
PMID: 39408683 PMC: 11476872. DOI: 10.3390/ijms251910356.
ACAD10 and ACAD11 allow entry of 4-hydroxy fatty acids into β-oxidation.
Paquay S, Duraffourd J, Bury M, Heremans I, Caligiore F, Gerin I Cell Mol Life Sci. 2024; 81(1):367.
PMID: 39174697 PMC: 11342911. DOI: 10.1007/s00018-024-05397-8.
Transition transferases prime bacterial capsule polymerization.
Litschko C, Di Domenico V, Schulze J, Li S, Ovchinnikova O, Voskuilen T Nat Chem Biol. 2024; 21(1):120-130.
PMID: 38951648 PMC: 11666461. DOI: 10.1038/s41589-024-01664-8.
Oral ribose supplementation in dystroglycanopathy: A single case study.
Thewissen R, Post M, Maas D, Veizaj R, Wagenaar I, Alsady M JIMD Rep. 2024; 65(3):171-181.
PMID: 38736632 PMC: 11078721. DOI: 10.1002/jmd2.12394.